6AZM
Crystal structure of the 580 germline antibody bound to circumsporozoite protein NANP 5-mer
Summary for 6AZM
Entry DOI | 10.2210/pdb6azm/pdb |
Descriptor | 580 germline antibody, light chain, 580 germline antibody, heavy chain, Circumsporozoite protein NANP 5-mer, ... (5 entities in total) |
Functional Keywords | malaria, circumsporozoite protein, fab, immune system |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 6 |
Total formula weight | 99385.81 |
Authors | Scally, S.W.,Bosch, A.,Triller, G.,Wardemann, H.,Julien, J.P. (deposition date: 2017-09-11, release date: 2017-12-13, Last modification date: 2024-04-03) |
Primary citation | Triller, G.,Scally, S.W.,Costa, G.,Pissarev, M.,Kreschel, C.,Bosch, A.,Marois, E.,Sack, B.K.,Murugan, R.,Salman, A.M.,Janse, C.J.,Khan, S.M.,Kappe, S.H.I.,Adegnika, A.A.,Mordmuller, B.,Levashina, E.A.,Julien, J.P.,Wardemann, H. Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies. Immunity, 47:1197-1209.e10, 2017 Cited by PubMed Abstract: Antibodies against the NANP repeat of circumsporozoite protein (CSP), the major surface antigen of Plasmodium falciparum (Pf) sporozoites, can protect from malaria in animal models but protective humoral immunity is difficult to induce in humans. Here we cloned and characterized rare affinity-matured human NANP-reactive memory B cell antibodies elicited by natural Pf exposure that potently inhibited parasite transmission and development in vivo. We unveiled the molecular details of antibody binding to two distinct protective epitopes within the NANP repeat. NANP repeat recognition was largely mediated by germline encoded and immunoglobulin (Ig) heavy-chain complementarity determining region 3 (HCDR3) residues, whereas affinity maturation contributed predominantly to stabilizing the antigen-binding site conformation. Combined, our findings illustrate the power of exploring human anti-CSP antibody responses to develop tools for malaria control in the mammalian and the mosquito vector and provide a molecular basis for the structure-based design of next-generation CSP malaria vaccines. PubMed: 29195810DOI: 10.1016/j.immuni.2017.11.007 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report